Company Directory > Biotech > Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) G. Brotzu
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) G. Brotzu and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
ARNAS G. Brotzu is a prominent public hospital and healthcare provider based in Cagliari, Sardinia. It serves as a regional reference center for oncology, pediatrics, and high-complexity medical procedures, operating across three main hospital sites: San Michele, Oncologico-Businco, and Microcitemico.
The institution is deeply committed to scientific research and high-quality clinical care. It functions as a key component of the Sardinian regional health system, focusing on advanced medical specialties, humanization of care, and the integration of clinical practice with academic and research activities.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Hospital & Healthcare / Clinical Research
SIZE & FINANCIALS
Employees:1001-5000
Founded:1982
Ownership:government
Status:operating
PIPELINE
Stage:Commercial
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Regione Autonoma della Sardegna (Regional Health System), AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Maurizio Marcias - Direttore Generale
Giorgio Carboni - Direttore Sanitario
Antonio Guerrieri - Direttore Amministrativo
LINKS
Website:aob.it
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) G. Brotzu. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.